These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 26448141)

  • 1. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
    Phyo AP; Jittamala P; Nosten FH; Pukrittayakamee S; Imwong M; White NJ; Duparc S; Macintyre F; Baker M; Möhrle JJ
    Lancet Infect Dis; 2016 Jan; 16(1):61-69. PubMed ID: 26448141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers.
    McCarthy JS; Rückle T; Elliott SL; Ballard E; Collins KA; Marquart L; Griffin P; Chalon S; Möhrle JJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study.
    Llanos-Cuentas A; Casapia M; Chuquiyauri R; Hinojosa JC; Kerr N; Rosario M; Toovey S; Arch RH; Phillips MA; Rozenberg FD; Bath J; Ng CL; Cowell AN; Winzeler EA; Fidock DA; Baker M; Möhrle JJ; Hooft van Huijsduijnen R; Gobeau N; Araeipour N; Andenmatten N; Rückle T; Duparc S
    Lancet Infect Dis; 2018 Aug; 18(8):874-883. PubMed ID: 29909069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers.
    McCarthy JS; Baker M; O'Rourke P; Marquart L; Griffin P; Hooft van Huijsduijnen R; Möhrle JJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2620-7. PubMed ID: 27272721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax Infection.
    Collins KA; Abd-Rahman AN; Marquart L; Ballard E; Gobeau N; Griffin P; Chalon S; Möhrle JJ; McCarthy JS
    J Infect Dis; 2022 Mar; 225(6):1062-1069. PubMed ID: 32479608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria.
    Adoke Y; Zoleko-Manego R; Ouoba S; Tiono AB; Kaguthi G; Bonzela JE; Duong TT; Nahum A; Bouyou-Akotet M; Ogutu B; Ouedraogo A; Macintyre F; Jessel A; Laurijssens B; Cherkaoui-Rbati MH; Cantalloube C; Marrast AC; Bejuit R; White D; Wells TNC; Wartha F; Leroy D; Kibuuka A; Mombo-Ngoma G; Ouattara D; Mugenya I; Phuc BQ; Bohissou F; Mawili-Mboumba DP; Olewe F; Soulama I; Tinto H;
    Malar J; 2021 May; 20(1):222. PubMed ID: 34011358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiroindolone KAE609 for falciparum and vivax malaria.
    White NJ; Pukrittayakamee S; Phyo AP; Rueangweerayut R; Nosten F; Jittamala P; Jeeyapant A; Jain JP; Lefèvre G; Li R; Magnusson B; Diagana TT; Leong FJ
    N Engl J Med; 2014 Jul; 371(5):403-10. PubMed ID: 25075833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
    Macintyre F; Adoke Y; Tiono AB; Duong TT; Mombo-Ngoma G; Bouyou-Akotet M; Tinto H; Bassat Q; Issifou S; Adamy M; Demarest H; Duparc S; Leroy D; Laurijssens BE; Biguenet S; Kibuuka A; Tshefu AK; Smith M; Foster C; Leipoldt I; Kremsner PG; Phuc BQ; Ouedraogo A; Ramharter M;
    BMC Med; 2017 Oct; 15(1):181. PubMed ID: 28988541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria.
    White NJ; Duong TT; Uthaisin C; Nosten F; Phyo AP; Hanboonkunupakarn B; Pukrittayakamee S; Jittamala P; Chuthasmit K; Cheung MS; Feng Y; Li R; Magnusson B; Sultan M; Wieser D; Xun X; Zhao R; Diagana TT; Pertel P; Leong FJ
    N Engl J Med; 2016 Sep; 375(12):1152-60. PubMed ID: 27653565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria.
    Charman SA; Arbe-Barnes S; Bathurst IC; Brun R; Campbell M; Charman WN; Chiu FC; Chollet J; Craft JC; Creek DJ; Dong Y; Matile H; Maurer M; Morizzi J; Nguyen T; Papastogiannidis P; Scheurer C; Shackleford DM; Sriraghavan K; Stingelin L; Tang Y; Urwyler H; Wang X; White KL; Wittlin S; Zhou L; Vennerstrom JL
    Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4400-5. PubMed ID: 21300861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Thriemer K; Degaga TS; Christian M; Alam MS; Rajasekhar M; Ley B; Hossain MS; Kibria MG; Tego TT; Abate DT; Weston S; Mnjala H; Rumaseb A; Satyagraha AW; Sadhewa A; Panggalo LV; Ekawati LL; Lee G; Anose RT; Kiros FG; Simpson JA; Karahalios A; Woyessa A; Baird JK; Sutanto I; Hailu A; Price RN
    Lancet; 2023 Dec; 402(10417):2101-2110. PubMed ID: 37979594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis.
    Commons RJ; Simpson JA; Thriemer K; Hossain MS; Douglas NM; Humphreys GS; Sibley CH; Guerin PJ; Price RN
    Lancet Infect Dis; 2019 Jan; 19(1):91-101. PubMed ID: 30587297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.
    McCarthy JS; Yalkinoglu Ö; Odedra A; Webster R; Oeuvray C; Tappert A; Bezuidenhout D; Giddins MJ; Dhingra SK; Fidock DA; Marquart L; Webb L; Yin X; Khandelwal A; Bagchus WM
    Lancet Infect Dis; 2021 Dec; 21(12):1713-1724. PubMed ID: 34715032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study.
    McCarthy JS; Lotharius J; Rückle T; Chalon S; Phillips MA; Elliott S; Sekuloski S; Griffin P; Ng CL; Fidock DA; Marquart L; Williams NS; Gobeau N; Bebrevska L; Rosario M; Marsh K; Möhrle JJ
    Lancet Infect Dis; 2017 Jun; 17(6):626-635. PubMed ID: 28363636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artefenomel: a promising new antimalarial drug.
    Rosenthal PJ
    Lancet Infect Dis; 2016 Jan; 16(1):6-8. PubMed ID: 26448142
    [No Abstract]   [Full Text] [Related]  

  • 17. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.
    Sulyok M; Rückle T; Roth A; Mürbeth RE; Chalon S; Kerr N; Samec SS; Gobeau N; Calle CL; Ibáñez J; Sulyok Z; Held J; Gebru T; Granados P; Brückner S; Nguetse C; Mengue J; Lalremruata A; Sim BKL; Hoffman SL; Möhrle JJ; Kremsner PG; Mordmüller B
    Lancet Infect Dis; 2017 Jun; 17(6):636-644. PubMed ID: 28363637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial.
    Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN
    Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Function Test Abnormalities in Experimental and Clinical
    Odedra A; Webb L; Marquart L; Britton LJ; Chalon S; Moehrle JJ; Anstey NM; William T; Grigg MJ; Lalloo DG; Barber BE; McCarthy JS
    Am J Trop Med Hyg; 2020 Nov; 103(5):1910-1917. PubMed ID: 32815508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.
    Karbwang J; Bangchang KN; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Lancet; 1992 Nov; 340(8830):1245-8. PubMed ID: 1359318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.